Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for treating autism spectrum disorders
IRCT201307303930N28Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Buspirone with Placebo (2 arms). Started Dec 2012; status: completed.
02
Drugs
buspirone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201307303930N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201307303930N28.